| EX1919 t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE |
| Specimen: |
3 mL (2 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Clinical history is mandatory. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 6 hrs |
72 hrs |
NA |
|
| Method: |
Real-Time PCR |
| Comment: |
Samples received on holidays will be reported in the next schedule/next working day. |
| Report: |
Contact us to know the TAT. |
| Usage: |
Chromosomal rearrangements can produce tumorigenic fusion genes. This mechanism is seen in 15-25% of Leukemias, Lymphomas & Sarcomas. Fusions can be produced by translocations, inversions, or deletions. Specific gene fusions in a patient’s tumor cells have an important bearing on the management & prognosis. This translocation results in the MLL- AF4 fusion gene and is associated with a poor outcome. It is found in >80% cases of infant ALL and is the most frequent MLL translocation in ALL but is rarely seen in AML. |
| Doctor Specialty: |
Oncologist |
| Disease: |
Leukemia |
| Components: |
|
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
MOLECULAR DIAGNOSTICS |
| Pre Test Information: |
Clinical history is mandatory. |
Reviews
There are no reviews yet.